TEDA BIOMEDICAL (08189): Lynn Li appointed as Co-CEO of the company.
Teda Biological (08189) announced that Ms. Lynn Li has been appointed as the co-CEO of the company, and Ms. Sun Li has been transferred from the CEO of the company to the co-CEO of the company, effective from March 31, 2026.
TEDA BIOMEDICAL (08189) announced that Ms. Lynn Li has been appointed as the Co-CEO of the company, and Ms. Sun Li has been reassigned from the position of CEO to Co-CEO of the company, effective from March 31, 2026.
Related Articles
LINK HOLDINGS (08237) released its annual financial performance, with a net profit attributable to shareholders of HK$178 million, turning a loss into profit compared with the previous year.
JISHENG GP HLDG (08133) announces financial results for 2025 with a net loss attributable to owners of the company of HK$3.977 million, representing a year-on-year increase of approximately 1.05 times.
ZIJING INTL FIN (08340) announces annual performance with a shareholder loss of 7.437 million Hong Kong dollars, a year-on-year increase of 200.24%.
LINK HOLDINGS (08237) released its annual financial performance, with a net profit attributable to shareholders of HK$178 million, turning a loss into profit compared with the previous year.
JISHENG GP HLDG (08133) announces financial results for 2025 with a net loss attributable to owners of the company of HK$3.977 million, representing a year-on-year increase of approximately 1.05 times.
ZIJING INTL FIN (08340) announces annual performance with a shareholder loss of 7.437 million Hong Kong dollars, a year-on-year increase of 200.24%.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
